Effect of Current Therapies Aimed at Preventing Variceal Rebleeding on Other Complications of Cirrhosis
Authors:
- 1 January 2016
- book chapter
- Published by Springer Nature
- p. 333-339
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- β‐Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta‐analysisLiver International, 2009
- Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding†Hepatology, 2008
- Comparative study between nadolol and 5‐isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trialAlimentary Pharmacology & Therapeutics, 2006
- Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleedingHepatology, 2005
- Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosisJournal of Hepatology, 2004
- Survival in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt: Eptfe–Covered Stentgrafts Versus Bare StentsHepatology, 2003
- Endoscopic Variceal Ligation Plus Nadolol and Sucralfate Compared With Ligation Alone for the Prevention of Variceal Rebleeding: A Prospective, Randomized TrialHepatology, 2000
- Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosisThe Lancet, 1991
- Meta-analysis of value of propranolol in prevention of variceal haemorrhageThe Lancet, 1990
- A Randomized Controlled Study of Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis: A Final ReportHepatology, 1984